Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.

The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 870 persons.
Sales per Businesses
201220132014
USD (in Million)%USD (in Million)%USD (in Million)%
Pharmaceutical Products585.98100%872.42100%1,173100%
Sales per Regions
201220132014
USD (in Million)%USD (in Million)%USD (in Million)%
United States538.2291.8%792.5290.8%1,00785.9%
Europe38.596.6%61.847.1%126.7210.8%
All Other9.171.6%18.062.1%38.763.3%
Ireland------
Italy------
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA512012Chairman & Chief Executive Officer
Russell J. Cox522012Chief Operating Officer & Executive Vice President
Matthew P. Young, MBA452013Chief Financial Officer & Executive Vice President
Mark G. Eller, PhD-2012Senior VP-Research & Clinical Development
Jeffrey K. Tobias, MD592011Chief Medical Officer
Paul L. Berns482010Independent Director
Bryan C. Cressey, MBA642012Independent Director
Patrick G. Enright, MBA532012Independent Director
Seamus C. Mulligan532012Director
Ken W. O'Keefe, MBA482012Independent Director
Shareholders
NameShares%
Fidelity Management & Research Co. 8,651,055 14.3%
Putnam Investment Management LLC 7,792,204 12.8%
The Vanguard Group, Inc. 3,477,267 5.73%
BlackRock Fund Advisors 2,813,176 4.64%
Janus Capital Management LLC 2,805,923 4.63%
Westfield Capital Management Co. LP 1,933,296 3.19%
Lone Pine Capital LLC 1,883,654 3.11%
BT Investment Management Ltd. (Investment Management) 1,455,087 2.40%
SSgA Funds Management, Inc. 1,207,001 1.99%
Seamus C. Mulligan 1,157,205 1.91%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
ABBVIE INC
BIOGEN INC
CELGENE CORPORATI..
ASTRAZENECA PLC
ALEXION PHARMACEU..
VERTEX PHARMACEUT..
UCB
GRIFOLS SA
JAZZ PHARMACEUTIC..
INDIVIOR PLC
CHONGQING ZHIFEI ..
-
CELLDEX THERAPEUT..
GREEN CROSS CORP
MEDY TOX INC
WALVAX BIOTECHNOL..
-
THERAVANCE INC
STAIDSON (BEIJING..
-
AMAG PHARMACEUTIC..
Sector Pharmaceuticals
Jazz Pharmaceuticals PLC : Connections
Thoma Cressey Bravo, Inc.
Vascular Cures
Cressey & Co. LP
Nueva School
Assistive Technology Group, Inc.
Circ Pharma Ltd.
Cressey & Co. Llc
Allergen Research Corp.
InfaCare Pharmaceutical Corp.
Stanford Health Care
Raven Biotechnologies, Inc.
Select Medical Corp.
Xanodyne Pharmaceuticals, Inc.
InfuScience, Inc.
Longitude Capital Management Co. LLC
Junior Achievement of Chicago
Beecken Petty O'Keefe & Co. LP
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2015 People , Fundamentals and Ownership   
Dynamic quotes  
ON
| OFF